- Researchers tested the efficacy of a drug combination for treating stage IV melanoma.
- They found that 71% of patients responded to the drug combination, and 50% had complete remission.
- The drug combination is now entering a larger trial with a more diverse cohort.
By Annie Lennon on January 3, 2023
Fact checked by Harriet Pike, Ph.D.
Call us at (888)-243-6602 to discuss how we can help keep your loved one safe and happy at home.